March 28, 2018

Information-Guided Neurological Care Is at Hand

The case for personalized brain mapping in complex disorders

18-NEU-822-Information-Guided-Neuro-650×450

By Andre Machado, MD, PhD; Imad Najm, MD; and Robert Fox, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Neurological and neurosurgical care in 2018 has expanded dramatically beyond the neurological examination and core operative procedures that formed the bedrock of practice in our disciplines. As contemporary care evolves, the importance of data that is highly personalized for each individual patient with a neurological condition becomes ever more apparent.

This increasing personalization of care has emerged just as the value of multidisciplinary collaboration has grown more and more evident. At Cleveland Clinic, we recognized this development over a decade ago by embracing an institute-based organizational structure. For individuals with brain and spine conditions, this structure brings together neurologists, neurosurgeons, neuroradiologists and neuroscientists in a Neurological Institute organized around patients’ disease-specific diagnostic and management needs rather than traditional departmental groupings. As a result, patients benefit from deeper collaboration across our institute’s 14 subspecialty centers.

When personalization meets cross-subspecialty collaboration

One area in which these two trends — increasing personalization and multidisciplinary collaboration — intersect with particular power is in what we describe as “information-guided care.” This concept represents a redefinition of neuroscience care that promotes cross-disciplinary collaboration in pursuit of more-personalized diagnosis and less-invasive management of the most challenging cases of various neurological diseases.

Our multidisciplinary teams in the Neurological Institute are at the forefront of this redefinition, which arises from the use of leading-edge imaging technologies, such as state-of-the-art 7T MRI, in innovative ways and combinations. The objective is threefold: (1) to better visualize brain anatomy, (2) to enhance understanding of function and (3) to provide accurate, noninvasive diagnosis of brain pathology without need for tissue biopsy.

Advertisement

Snapshots of information-guided care in action

Our multidisciplinary Neurological Institute teams recently published here on Consult QD progress reports from various fronts in their pursuit of personalized, information-guided neurological care. We urge you to check out these brief, image-rich reports for a more detailed take on the fascinating work underway. These reports fall into three broad categories.

First is a series of profiles of how our teams have been untangling the complex connectivities of the brain to create anatomo-functional maps to help tailor personalized treatment options. The specific work covered includes:

Next comes a trio of reports on how we are using novel analytic methods and machine learning to make the most of MRI by enhancing the processing of otherwise routine imaging data. These approaches — which include computer-assisted morphometric assessment of MRI findings, integration of machine learning with MRI post-processing, and quantitative MRI volumetric analysis — promise more straightforward diagnosis across various neurological conditions, without the need for more-complex and invasive diagnostic methods.

We round out our reports with two short articles reviewing our work on clinical application of a novel PET radiotracer that preferentially binds to molecular components of myelin and provides quantitative imaging of brain white matter integrity beyond what’s possible with existing MRI methods. The first article explains the technology, called myelin PET, and how it adds a new dimension to brain mapping. The second article profiles how we have started to use myelin PET to improve lesion identification in pharmacoresistant epilepsy, with studies in multiple sclerosis, stroke rehabilitation and other conditions planned.

Advertisement

We believe this information-guided approach to neuroscience care designed and validated by expert multidisciplinary teams will lead to enhanced diagnosis, more-personalized treatment options and improved outcomes for patients with the most complex neurological diseases.

Dr. Machado is Chairman of Cleveland Clinic Neurological Institute. Dr. Najm is Neurological Institute Vice Chairman for Strategy and Development. Dr. Fox is Neurological Institute Vice Chairman for Research.

Related Articles

23-NEU-3516858-brain-trauma-650×450
January 30, 2023
Neurotrauma Guidelines: Where They’ve Been, Where They’re Headed and How to Make the Most of Them

Q&A with Brain Trauma Foundation guideline architect Gregory Hawryluk, MD, PhD

20-NEU-2020111 neuroimmunology_650x450
December 30, 2020
Autoimmune Neurologic Disorders: Treatable Conditions That Should Not Be Missed

Q&A with newly arrived autoimmune neurology specialist Amy Kunchok, MD

20-NEU-1984276 multimodal-monitoring_650x450
October 6, 2020
Multimodal Monitoring in the Neuro ICU: Essentials for Clinicians (Podcast)

A neurocritical care specialist shares what’s spurring growth of this new evaluation approach

20-NEU-1931313-Parkinsons-brain-650×450
September 2, 2020
More Patients Can Benefit From Functional Interventions for Parkinson’s, Essential Tremor (Podcast)

Focused ultrasound offers a newer alternative to deep brain stimulation

frailty
August 18, 2020
The Importance of Screening for Frailty in Patients with Spinal Conditions (Podcast)

Prehabilitation can help improve outcomes after spine surgery

central vein sign in multiple sclerosis
August 4, 2020
New Frontiers in Diagnosing and Monitoring Multiple Sclerosis (Podcast)

Get ready for central vein sign and optical coherence tomography

20-NEU-1938374-migraine_650x450
August 3, 2020
CGRP Antagonists for Decreasing Migraine Frequency: A Primer

How these new drugs fit into practice two years out from their first approvals

20-NEU-1892171 CQD_650x450_CCC-1901608_06-03-20_0443
July 2, 2020
What’s Afoot and What’s Ahead for Physical Medicine and Rehabilitation

A conversation on the state of physiatry with the AAPM&R’s Vice President

Ad